• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:陈嫣,王秀娣.杏香兔耳风片治疗宫颈糜烂合并盆腔炎疗效观察[J].中国现代应用药学,2010,27(1):66-68.
.Observation of the Treatment of Ainsliaea Frograns Champ to Chronic Cervicitis Complicated Pelvistis[J].Chin J Mod Appl Pharm(中国现代应用药学),2010,27(1):66-68.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2429次   下载 2014 本文二维码信息
码上扫一扫!
分享到: 微信 更多
杏香兔耳风片治疗宫颈糜烂合并盆腔炎疗效观察
陈嫣,王秀娣
作者单位
摘要:
目的 探讨中药杏香兔耳风片对宫颈糜烂合并慢性盆腔炎的疗效。方法 80例分成2组,治疗组50例,对照组30例。2组均在临睡前阴道注入重组人干扰素α-2b凝胶1 g,1次·d-1,共60 d;治疗组加用口服杏香兔耳风片4片·次-1,3次·d-1,共60 d;结果 宫颈糜烂治疗1月后,治疗组有效率94%,对照组80%,2组疗效有显著性差异(P<0.05);治疗2月后,治疗组有效率100%,对照组94%,2组比较有显著性差异(P<0.01)。治疗组阴道排液量、出血量明显减少,排液时间及出血时间亦明显缩短,2组比较差异明显(P<0.01)。盆腔炎治疗1月后治疗组有效率92%,对照组46.67%,2组比较有显著性差异(P<0.01)。结论 杏香兔耳风片治疗宫颈糜烂和盆腔炎疗效显著。
关键词:  杏香兔耳风片  重组人干扰素α-2b凝胶  宫颈糜烂  盆腔炎
DOI:
分类号:
基金项目:
Observation of the Treatment of Ainsliaea Frograns Champ to Chronic Cervicitis Complicated Pelvistis
CHEN Yan  WANG Xiudi*
Abstract:
OBJECTIVE To investigate the efficacy of ainsliaea fragrans champ (AFC) in treatment of chronic cervicitis complicated pelvicellulitis. METHODS 80 patients were divided into two groups: group I(treatment group, n=50) and group II(control group, n=30). Both of two groups were treated with recombinant human interferon α-2b gel (RHI) before sleeping for 60 days, meanwhile, group I were treated with AFC 4 pills tid.p.o. . RESULTS After a month, the effective rate of cervical erosion in group I was 94%, in group II was 80% (P<0.05), and two months later they were 100% and 94%(P<0.01), respectively. The time and volume of excretory fluid and bleeding in group I were both evidently shortened and decreased with very significant difference compared with group II(P<0.01). After a month, the effective rate of pelvicellulitis in group I was 92% and 46.67% in groupII(P<0.01). CONCLUSION AFC has good efficacy on treating chronic cervical erosion complicated pelvicellulitis.
Key words:  ainsliaea fragrans champ  recombinant human interferon α-2b gel  cervical erosion  pelvicellulitis
扫一扫关注本刊微信